Impact of Meal Composition and Alcohol Consumption on Postprandial Glycemic Control in Subjects With Type 1 Diabetes

Diabetes Mellitus, Type 1 Clinical Trial

Official title:

Evaluación Del Impacto de la composición Nutricional de la Ingesta y Del Consumo de Alcohol en el Control glucémico Postprandial en Pacientes Con Diabetes Tipo 1

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03320993
• Other study ID #: DPI2016-78831-C2-1-R_alcohol
• Status: Completed
• Phase: N/A
• Start date: October 25, 2018
• Est. completion date: January 31, 2020

Study information

• Verified date: March 2020
• Source: Universitat Politècnica de València
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Postprandial glucose control is a challenging issue in everyday diabetes care. Indeed, excessive postprandial glucose excursions are the major contributors to plasma glucose (PG) variability in subjects with type 1 diabetes (T1DM). In addition, the poor reproducibility of postprandial glucose response is burdensome for patients and healthcare professionals.

To date, the majority of prandial insulin dosing algorithms for subjects with T1DM considers only the carbohydrate (CHO) content of the meal. However, there is evidence (although with a certain degree of heterogeneity) that meal composition significantly affects postprandial glucose control, contributing to glycemic variability. Moreover, despite the high prevalence of alcohol consumption among patients with T1DM (about 30%, similar to that of the general population), data regarding its effect on the postprandial period are very limited.

This project will evaluate the effect of meal composition and alcohol consumption on postprandial glucose control in subjects with T1DM under intensive insulin treatment.

Description:

Randomized, prospective, single-centre (Hospital Francesc de Borja, Gandia, Spain), single-blind (analysis), three -way, crossover study on type 1 diabetic subjects (n=12) under intensive insulin treatment.

Aim:

To assess the effect of mixed meal composition on postprandial glycemic control, in subjects with type 1 diabetes:

1. Combined effect of proteins and fats

2. Effect of alcohol consumption

Methods:

Each subject will undergo three mixed meal test studies (on three different days), with identical CHO content: On one occasion a low fat-low protein meal will be given, and on another a high fat-high protein one, both consumed with a non-alcoholic drink; on a third occasion the same high fat-high protein meal will be consumed, but this time accompanied by an equal volume of an alcoholic drink.

Patients will arrive at the research unit at 8:00 am and their blood glucose will be stabilized around 90 mg/dl before each mixed meal test. After the mixed meal, blood will be drawn every 5-30 min during a 6 hour post-prandial period to assess plasma glucose, hormones and metabolites concentration.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 12
• Est. completion date: January 31, 2020
• Est. primary completion date: January 23, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

Patients with type 1 diabetes mellitus for more than one year, aged between 18 and 60 years; on intensive insulin therapy by means of CSII (continuous subcutaneous insulin infusion) or MDI (multiple daily injections) for at least 6 months before screening; glycosylated haemoglobin of 6-8.5%; without severe chronic micro- and macroangiopathic diabetic complications and with a body mass index (BMI) between 18 and 30 kg/m2.

Exclusion Criteria:

• Pregnancy and lactation

• Hypoglycemia unawareness

• Fatal or progressive disease

• Drugs or alcohol abuse

• HIV, active hepatitis B, active hepatitis C

• Hepatic disease (aminotransferases AST or ALT >2 times above normal)

• Clinically relevant microangiopathic disease, or other diseases that may interfere with participation in the study or data analysis

• Pre-planned surgery

• Blood donation in the previous 3 months for men and 6 months for women

• Mental conditions that may interfere with the subject's comprehension of the aims and possible consequences of the study

• Non-compliant subjects

• Use of experimental medications or devices during the previous 30 days

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetes Mellitus, Type 1

Intervention

Other:
• Mixed meal with different macronutrient composition
A mixed meal with identical amount of carbohydrates but different content of protein, fat and alcohol will be given

Locations

Country	Name	City	State
Spain	Hospital Francesc de Borja	Gandia	Valencia

Sponsors (3)

Lead Sponsor	Collaborator
Jorge Bondia	Hospital Francesc de Borja, Gandia, Spain, Ministerio de Economía y Competitividad, Spain

Country where clinical trial is conducted

Spain, 

References & Publications (5)

Barnard K, Sinclair JM, Lawton J, Young AJ, Holt RI. Alcohol-associated risks for young adults with Type 1 diabetes: a narrative review. Diabet Med. 2012 Apr;29(4):434-40. doi: 10.1111/j.1464-5491.2012.03579.x. Review. — View Citation

Bell KJ, Smart CE, Steil GM, Brand-Miller JC, King B, Wolpert HA. Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care. 2015 Jun;38(6):1008-15. doi: 10.2337/dc15-0100. Review. — View Citation

Bell KJ, Toschi E, Steil GM, Wolpert HA. Optimized Mealtime Insulin Dosing for Fat and Protein in Type 1 Diabetes: Application of a Model-Based Approach to Derive Insulin Doses for Open-Loop Diabetes Management. Diabetes Care. 2016 Sep;39(9):1631-4. doi: 10.2337/dc15-2855. Epub 2016 Jul 7. — View Citation

Kerr D, Cheyne E, Thomas P, Sherwin R. Influence of acute alcohol ingestion on the hormonal responses to modest hypoglycaemia in patients with Type 1 diabetes. Diabet Med. 2007 Mar;24(3):312-6. — View Citation

Turner BC, Jenkins E, Kerr D, Sherwin RS, Cavan DA. The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care. 2001 Nov;24(11):1888-93. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Time in range	Time in acceptable glucose range (70-180 mg/dl)	6 hours (time in range during the 6 hour post-prandial period)
Other	C Max	Maximum of plasma glucose concentration	6 hours (maximum plasma glucose concentration during the 6 hour post-prandial period)
Other	T max	Time of Maximum plasma glucose concentration	6 hours (Time of maximum plasma glucose concentration during the 6 hour post-prandial period)
Other	Hormones and metabolites	Plasma concentration of free fatty acids, beta-OH-butyrate, lactate, alanine, counterregulatory hormones	6 hours (plasma hormones and metabolites will be measured every 30 minutes during the 6-hour post-prandial period)
Primary	Plasma Glucose	Post-prandial plasma glucose time series	6 hours (plasma glucose will be measured every 5-15 minutes during the 6-hour post-prandial period of each mixed meal test).
Secondary	AUC-PG	Area Under the Curve (AUC) of Plasma Glucose in the 0-6h, 0-3h and 3-6h post-prandial periods	AUC of plasma glucose will be calculated for the whole 6 hour post-prandial period, for the early 0-3 hour post-prandial period and for the late 3-6 hour post-prandial period.